Sign in
Download Opera News App

DISEASE PREVENTION AND TREATMENT

Arcturus Therapeutics Receives Approval from Health Sciences Authority to Proceed with Phase 2 Study of Vaccine Candidate

Arcturus Therapeutics Receives Approval from Health Sciences Authority to Proceed with Phase 2 Study of Vaccine Candidate

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) reported approval from the Singapore Health Sciences Authority to commence its Phase 2 clinical study of its vaccine candidate ARCT-021. The study will utilize its favorable phase ½ study results, including supportive preclinical data. “We are pleased to advance ARCT-021 into a Phase 2 study...

Read Full Story
ARCT Arcturus Arcturus Therapeutics Health Sciences Authority Singapore Health Sciences Authority Steve Hughes

Top News

US POLITICS

How soon might you receive a $1,400 stimulus check?

msn.com
How soon might you receive a $1,400 stimulus check?

US POLITICS

How soon might you receive a $1,400 stimulus check?

msn.com

US POLITICS

Schumer leads Dems to messy but major win on Covid aid

politico.com
Schumer leads Dems to messy but major win on Covid aid

US POLITICS

Schumer leads Dems to messy but major win on Covid aid

politico.com

Comments

Load app to read more comments